Skip to main content
. 2019 Sep 2;20(17):4291. doi: 10.3390/ijms20174291

Figure 2.

Figure 2

Schematic representation of the mechanism of action of flavonoids as RTK inhibitors, by inhibiting key signal transduction pathways involved in lung cancer.